MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

The pet spending surge during the pandemic subsided but the current one is set to grow as much as 60% and continue much ...

Tourlite Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the ...

Dell Technologies (DELL) closed at $152.41 in the latest trading session, marking a -1.44% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.37% for the day.

A witch, a bunch of anthropomorphic animals, and a 9-foot-tall alien walk into a theater. Does a meme stock survive its uninspiring Q3 earnings? Such are the riddles that plague us these days. Such is ...

While gas prices in Oregon continue to decline, prices in many other states and the national average are climbing, AAA Oregon ...

Stocks rallied on Monday as investors digested fresh comments from top Fed officials and AI companies rebounded from last ...

Discover three stock picks for April 2021 in the energy and financials sectors! Capitalize on market dips and potential ...

According to JPMorgan's Samik Chatterjee, the trio's combined capex jumped 23% quarter-over-quarter and 85% year-over-year to nearly $80 billion in the September quarter — and the spree isn't stopping ...

The recent stock splits are an excellent opportunity to revisit how splits affect investors. ASML Holding trades above $1,000 per share and hasn't split its stock in over a decade. Meta Platforms ...